[{"AccountsPayableCurrent_0_Q3_USD":8917000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":78536000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":216410000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":54274000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":126596000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":115148000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":292714000.0,"NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_3_Q3_USD":365139000.0,"NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_3_Q3_USD":0.0,"NumberOfOperatingSegments_3_Q3_segment":3.0,"NetIncomeLoss_3_Q3_USD":126596000.0,"NumberOfReportableSegments_3_Q3_segment":3.0,"OperatingIncomeLoss_1_Q3_USD":156873000.0,"OperatingIncomeLoss_3_Q3_USD":403560000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":10487000.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q3_USD":1273000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":1104000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":1371000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":1336000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":117000.0,"OperatingLeasesRentExpenseNet_1_Q3_USD":100000.0,"NumberOfReportingUnits_3_Q3_reportingUnit":3.0,"NetIncomeLoss_1_Q3_USD":54274000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":310403000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":111317000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":11472000.0,"InventoryNet_0_Q3_USD":56246000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":19344000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":25430000.0,"Liabilities_0_Q3_USD":1441067000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1894683000.0,"LiabilitiesCurrent_0_Q3_USD":114352000.0,"LongTermDebt_0_Q3_USD":531584000.0,"LongTermDebtCurrent_0_Q3_USD":6000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":6000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":6000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":6000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":6000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":1500000.0,"LongTermDebtNoncurrent_0_Q3_USD":525584000.0,"ManagementFeeExpense_1_Q3_USD":0.0,"ManagementFeeExpense_3_Q3_USD":0.0,"MinorityInterest_0_Q3_USD":150979000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q3_USD":50001000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3_Q3_USD":106204000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-110051000.0,"OperatingLeasesRentExpenseNet_3_Q3_USD":2100000.0,"InterestPaidNet_3_Q3_USD":23030000.0,"OtherAssetsNoncurrent_0_Q3_USD":4106000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":39000.0,"ResearchAndDevelopmentInProcess_1_Q3_USD":0.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":127450000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":204810000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":570796000.0,"SaleLeasebackTransactionCurrentPeriodGainRecognized_3_Q3_USD":0.0,"SaleLeasebackTransactionCurrentPeriodGainRecognized_1_Q3_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":25189000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":72511000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":6046000.0,"ShareBasedCompensation_3_Q3_USD":8228000.0,"StockholdersEquity_0_Q3_USD":302637000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":453616000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q3_shares":0.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":0.0,"StockIssuedDuringPeriodValueConversionOfUnits_1_Q3_USD":0.0,"StockIssuedDuringPeriodValueConversionOfUnits_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":785000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":257799000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":258028000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_1_Q3_USD":1950000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":4500000.0,"RepaymentsOfLongTermCapitalLeaseObligations_3_Q3_USD":582000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1553000.0,"OtherNoncashIncomeExpense_3_Q3_USD":875000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":78000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":78000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":9188000.0,"PaymentsToMinorityShareholders_3_Q3_USD":106298000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q3_USD":0.0,"PreferredStockDividendsAndOtherAdjustments_3_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":17395000.0,"ProceedsFromDivestitureOfBusinessesNetOfCashDivested_3_Q3_USD":119957000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":0.0,"ProceedsFromSaleOfBuildings_3_Q3_USD":548000.0,"ProceedsFromStockPlans_3_Q3_USD":1329000.0,"ProfessionalFees_1_Q3_USD":1034000.0,"ProfessionalFees_3_Q3_USD":2038000.0,"ProfitLoss_3_Q3_USD":343006000.0,"ProfitLoss_1_Q3_USD":132810000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":108322000.0,"RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology_1_Q3_USD":-3246000.0,"RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology_3_Q3_USD":-9132000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":55000.0,"InterestExpense_3_Q3_USD":25827000.0,"InterestExpense_1_Q3_USD":8545000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":121225000.0,"CapitalLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":5109000.0,"CapitalLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":5014000.0,"CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments_0_Q3_USD":25249000.0,"CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1_0_Q3_USD":45184000.0,"CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments_0_Q3_USD":19935000.0,"CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":1070000.0,"CapitalLeasesIncomeStatementAmortizationExpense_1_Q3_USD":1031000.0,"CapitalLeasesIncomeStatementAmortizationExpense_3_Q3_USD":2080000.0,"Cash_0_Q3_USD":547898000.0,"CapitalLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":5071000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":547898000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTax_1_Q3_USD":54313000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":126640000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":78536000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":216421000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":132849000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":343061000.0,"ContractWithCustomerAssetNetCurrent_0_Q3_USD":0.0,"ContractWithCustomerLiability_0_Q3_USD":69900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":311714000.0,"CapitalLeasesFutureMinimumPaymentsDueCurrent_0_Q3_USD":4648000.0,"CapitalLeaseObligationsNoncurrent_0_Q3_USD":55324000.0,"CapitalLeaseObligationsCurrent_0_Q3_USD":1174000.0,"AccountsReceivableNetCurrent_0_Q3_USD":65939000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":31422000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":0.0,"AdditionalPaidInCapital_0_Q3_USD":172611000.0,"AdjustmentForAmortization_1_Q3_USD":4604000.0,"AdjustmentForAmortization_3_Q3_USD":14685000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3567000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":8228000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3567000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8228000.0,"AmortizationOfFinancingCosts_3_Q3_USD":1995000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":14685000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":283000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":292000.0,"Assets_0_Q3_USD":1894683000.0,"AssetsCurrent_0_Q3_USD":687478000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q3_USD":-366000.0,"BusinessCombinationAcquisitionRelatedCosts_3_Q3_USD":1550000.0,"BusinessCombinationIntegrationRelatedCosts_1_Q3_USD":21000.0,"BusinessCombinationIntegrationRelatedCosts_3_Q3_USD":-777000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":826000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":66715000.0,"CostOfRevenue_1_Q3_USD":32047000.0,"CostOfRevenue_3_Q3_USD":99928000.0,"CostsAndExpenses_1_Q3_USD":47937000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":14417000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":14417000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":14417000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":194721000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":121225000.0,"GainLossOnSaleOfBusiness_1_Q3_USD":11249000.0,"GainLossOnSaleOfBusiness_3_Q3_USD":11249000.0,"Goodwill_0_Q3_USD":152766000.0,"GoodwillTransfers_3_Q3_USD":-71509000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":151652000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":386943000.0,"IncomeTaxesPaid_3_Q3_USD":16569000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":18842000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":43937000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1543000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":18851000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-10076000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-11346000.0,"IncreaseDecreaseInInventories_3_Q3_USD":26263000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":267000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":7590000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":3654000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":109174000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":14600000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":18400000.0,"CostsAndExpenses_3_Q3_USD":167236000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":545500000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_3_Q3_USD":0.0,"DeferredFinanceCostsNet_0_Q3_USD":13916000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":820786000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":29438000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":0.0,"Depreciation_1_Q3_USD":2472000.0,"Depreciation_3_Q3_USD":6623000.0,"DilutiveSecurities_1_Q3_USD":87000.0,"DilutiveSecurities_3_Q3_USD":102000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":1298000.0,"DueToRelatedPartiesCurrentAndNoncurrent_0_Q3_USD":745600000.0,"DueToRelatedPartiesNoncurrent_0_Q3_USD":744254000.0,"EarningsPerShareBasic_1_Q3_USD":0.46,"EarningsPerShareBasic_3_Q3_USD":1.16,"EarningsPerShareDiluted_1_Q3_USD":0.45,"EarningsPerShareDiluted_3_Q3_USD":1.14,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.124,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.114,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":45000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":73496000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":118433000.0,"Ticker":"MRVI","CIK":"1823239","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","OfficialName":"Maravai LifeSciences Holdings Inc. Class A Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4495627373.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]